Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19

Background/Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased risk of acute ischemic stroke (AIS), however, there is a paucity of data regarding outcomes after administration of intravenous tissue plasminogen activator (IV tPA) for stroke in patients with COVID-19. Methods: We...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Stroke Cerebrovasc Dis
Prif Awduron: Carneiro, Thiago, Dashkoff, Jonathan, Leung, Lester Y., Nobleza, Christa O'Hana S., Marulanda-Londono, Erika, Hathidara, Mausaminben, Koch, Sebastian, Sur, Nicole, Boske, Alexandra, Voetsch, Barbara, Aboul Nour, Hassan, Miller, Daniel J, Daneshmand, Ali, Shulman, Julie, Curiale, Gioacchino, Greer, David M., Romero, Jose Rafael, Anand, Pria, Cervantes-Arslanian, Anna M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Inc. 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383145/
https://ncbi.nlm.nih.gov/pubmed/33066885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105201
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg